Bulasa, Antonite A.
HRN: 22-90-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
METRONIDAZOLE 500MG (TAB)
03/25/2024
04/01/2024
PO
500mg
TID X 7 Days
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes